Europe Platelet Rich Plasma (PRP) Market

Europe platelet rich plasma (PRP) sales will grow through 2035, led by autologous PRP at 84.3% share of the product origin segment in 2025. Cosmetic surgery holds 84.3% share of the indication segment in 2025. The market was valued at USD 62.4 million in 2025 and is projected to reach USD 94.2 million.